3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
7
Motor Activity
5
Rectal Neoplasms
3
Pain, Postoperative
3
Vomiting
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nausea
2
Lung Neoplasms
2
Liver Diseases
2
Leukemia, Myeloid, Acute
2
Fatigue
2
Colorectal Neoplasms
2
Agnosia
2
Uterine Cervical Neoplasms
1
Ulcer
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Postoperative Cognitive Complications
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Pediatric Brain Tumor
1
Pathologic Processes
1
Papillomavirus Infections
1
Pain
1
Osteolysis
1
Multiple Myeloma
1
Malnutrition
1
Interventions
pembrolizumab
5
enfortumab vedotin
3
Gemcitabine
3
dodecyl maltoside
2
Sunitinib
2
Cisplatin
2
zidovudine 5'-monophosphate-mannose-albumin conjugate
1
tucatinib
1
testosterone 17 beta-cypionate
1
temsirolimus
1
relatlimab
1
palbociclib
1
niraparib
1
galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20
1
cabozantinib
1
Valproic Acid
1
Urinary Diversion
1
Trastuzumab
1
Testosterone Propionate
1
Standard of Care
1
Sirolimus
1
Rivaroxaban
1
Ringer's acetate
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Psychiatric Nursing
1
Practice Guidelines as Topic
1
Physical Therapy Modalities
1
Nivolumab
1
Multiparametric Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urologic Neoplasms
×
Control Groups
×
1 year
×
Clear all
No trials found.